Colgate-Palmolive said consumers have been buying less toothpaste and soap as they brace for economic uncertainty, leading ...

Q1 2025 Management View CEO Noel Wallace highlighted that despite increased volatility in 2025, the company is ...

We look at Colgate-Palmolive Company's Q1 results, market challenges, and tariff impacts. Read to see if the CL stock is ...

Colgate-Palmolive on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, ...

EDT Colgate-Palmolive (CL) says to take prudent pricing to mitigate tariff impactStay Ahead of the Market: Discover outperforming stocks ...

JP Morgan analyst Andrea Teixeira maintained an Overweight rating and slashed the price target from $99 to $95 on April 11, ...

Colgate-Palmolive (NYSE: CL) shares rose premarket after Q1 FY25 earnings beat expectations. Revenue hit $4.91B, topping estimates, with 1.4% organic sales growth and $0.91 EPS exceeding forecasts.

Shares in consumer products group Colgate-Palmolive (CL) shone brightly in early trading today as it reported forecast beating first quarter ...

Higher costs could further dampen consumer demand. For Colgate, tariffs will drive raw and packaging materials costs higher ...

Investing.com - Colgate-Palmolive (NYSE: CL) has slashed its full-year guidance for organic sales, becoming the latest ...

Dan Loeb’s Third Point Capital has built a stake in Tylenol and Neutrogena maker Kenvue, becoming the third activist hedge ...